Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041957 | SCV000065653 | benign | not specified | 2008-03-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000041957 | SCV000169756 | benign | not specified | 2011-08-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000041957 | SCV000317217 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Invitae | RCV001514233 | SCV001722030 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001273700 | SCV001750312 | benign | Usher syndrome type 2A | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003888414 | SCV004707905 | benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Natera, |
RCV001273700 | SCV001457069 | benign | Usher syndrome type 2A | 2020-09-16 | no assertion criteria provided | clinical testing |